Pharmacological inhibition of P300 with C646 ameliorates LPS-induced acute lung injury by modulating CXCL1 in M1 alveolar macrophages
- 25 November 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 144, 113674
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The role of lung macrophages in acute respiratory distress syndromeInflammation Research, 2022
- Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine SignalingHepatology, 2021
- p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate CellsHepatology, 2019
- Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α ReleaseImmunity, 2015
- AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approachesFrontiers of Medicine, 2012
- Small Molecule Inhibitors of Histone Acetyltransferases as Epigenetic Tools and Drug CandidatesArchiv der Pharmazie, 2011
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule InhibitorChemistry & Biology, 2010
- Pharmacological targeting of lysine acetyltransferases in human disease: a progress reportDrug Discovery Today, 2007
- Structural Basis for Cooperativity in Recruitment of MAML Coactivators to Notch Transcription ComplexesCell, 2006
- Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptidesVirology, 1985